Üsküdar Üniversitesi’s R&D and Innovation Policies Directorate organized the program “Step-by-Step Bio-entrepreneurship: A Roadmap for Biotechnology Entrepreneurs and Investors.” In the program, attended by Boğaziçi University Lecturer Dr. Sevgi Salman Ünver as a speaker, Ünver stated that if we are talking about innovations today, it is fundamentally based on innovation. Stating that “we are now more hopeful for many patients,” Ünver noted that the vaccine process also tested technology.
“If we are talking about innovations today, it is fundamentally based on innovation”
In the program held via Zoom webinar, moderated by Corporate Formation and Entrepreneurship Expert Cihan Kaplan, Genomedis Biotechnology Founder Dr. Sevgi Salman Ünver spoke about the development of innovation, stating, “Innovation has emerged in different forms over the years. If we are talking about innovations today, if we are talking about new types of solutions, innovation fundamentally lies at their core. Old-style innovation was a more closed system. These were environments where large companies mostly led or certain institutions were the driving force. After the 2000s, by sharing information and collaborating more, open innovation was adopted. In open innovation, there was a point where it fell short in developing innovation. Where it fell short, the constellation innovation model was adopted.”
“We are now even more hopeful for many patients”
Referring to biotechnology processes and the Covid-19 process, Ünver said: “For years, biotechnology was seen as an important field for production. However, due to certain technical and technological inadequacies, biotechnology could not progress as fast as it had envisioned. For example, gene technologies have always been a dream, but technical issues slowed this development somewhat. Especially with the advancements in information technologies, biotechnology had begun to be a locomotive for producing innovation. With Covid-19, the process accelerated significantly. Treatment models that had been trying to be developed for years, and goals that had been strived for over many years, made RNA technology applicable with extraordinary acceleration in an extraordinary process. The vaccine process tested technology. We are now even more hopeful for many patients.”
“We see that biocomputers will gain significant importance”
Dr. Sevgi Salman Ünver said, “When we examine a report on what the most important fields will be in the age of biotechnology, we see that biocomputers will gain significant importance. Processing, coding, using, storing, converting live data into products, and artificial intelligence are among the most important topics for the future. Also very important are biomachines – systems working integrated with living systems, brain-machine interfaces, and Neuralink topics. Perhaps we will enter a process where we will communicate with machines.”